The Progeny of IG Farben Corruption in the Pharmaceutical Industry is a Minimal Risk Enterprise
Despite rules changes intended to benefit consumers over the past 60 years, multiple felon Big Pharma continues to play by its own rules. By M. Dennis Paul
